source
- STAT+: Capsida says it still doesn’t know what caused gene therapy deathSome in the gene therapy field lament lost time while Capsida kept silent about the brain receptor it was targeting when things went wrong.STAT · 2mo ago↗ source
- A year after Vertex’s big launch, pain drug research faces a pivotal momentJournavx revived an area of development long considered a graveyard. Can any other pain drugs keep investor excitement going?BioPharma Dive · 2mo ago↗ source
- Flagship startup Serif says it has solved non-viral gene therapy in monkeysBOSTON — Serif Biomedicines, a startup launched last month by Flagship Pioneering, believes it has solved two technical challenges that have long prevented gene therapy from being delivered without…Endpoints